Grove Biopharma to Join ACS Fall 2025 Materials Biology Symposium
Grove Biopharma to Showcase Breakthrough Bionic Biologics™ at ACS Fall 2025 Symposium on Materials Biology Grove Biopharma, a private biotechnology company advancing an innovative therapeutic approach it calls Bionic Biologics™,…
FluMist, the Only Nasal Spray Flu Vaccine in the U.S., Now Offered Through Home Delivery
AstraZeneca Launches FluMist Home: First Nationwide At-Home Delivery Service for Needle-Free Influenza Vaccination AstraZeneca has announced the launch of FluMist Home, a pioneering direct-to-consumer initiative that will allow individuals and…
RenovoRx Posts Q2 2025 Growth, Phase III Trial Cleared to Continue
RenovoRx Reports Strong Q2 2025 Revenue Growth and Receives Positive Independent Committee Recommendation to Continue Phase III TIGeR-PaC Trial RenovoRx, Inc. (Nasdaq: RNXT), a clinical-stage life sciences company pioneering targeted…
Omeros Corporation Announces Financial Results for Q2 2025
Omeros Corporation Reports Second Quarter 2025 Financial Results, Advances Narsoplimab Regulatory Reviews, and Strengthens Balance Sheet Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company dedicated to developing novel therapeutics for serious…
ScaleReady Awards G-Rex® Grant to Gates Institute’s Translational Sciences Laboratory
ScaleReady Awards $300,000 G-Rex® Grant to Gates Institute’s Translational Sciences Laboratory to Advance Modular CAR T-Cell Manufacturing ScaleReady, a joint venture formed by Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady,…
SAPPHIRE Trial: Apitegromab Boosts Motor Function in SMA, Published in The Lancet Neurology
Scholar Rock Announces Landmark Lancet Neurology Publication of Pivotal Phase 3 SAPPHIRE Trial Results for Apitegromab in Spinal Muscular Atrophy Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company dedicated to…
Nu-Tek BioSciences Showcases Animal-Free Cell Culture at BPI East 2025
Nu-Tek BioSciences to Showcase 100% Animal-Free Peptones and Yeast Extracts at BPI East 2025, Driving the Future of Sustainable Cell Culture and Fermentation In an era where biopharmaceutical manufacturers are…
Cybin Announces Key Milestone Achievements and First Quarter FY2026 Financial Update
Cybin Announces Major Clinical and Regulatory Milestones Alongside First Quarter Fiscal Year 2026 Financial Results Cybin Inc. (NYSE American: CYBN) (Cboe Canada: CYBN), a clinical-stage breakthrough neuropsychiatry company focused on…
Alto Neuroscience Names Raymond Sanchez, M.D., Biotech Industry Veteran, to Board of Directors
Alto Neuroscience Appoints Raymond Sanchez, M.D., to Board of Directors, Strengthening Leadership as Company Advances Late-Stage Precision Psychiatry Pipeline Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company pioneering…
Innoviva’s ZEVTERA® & XACDURO® Nominated for 2025 Prix Galien USA Award
Innoviva Specialty Therapeutics Earns Dual Nominations for 2025 Prix Galien USA Best Pharmaceutical Product Award for ZEVTERA® and XACDURO® Innoviva Specialty Therapeutics, a wholly owned subsidiary of Innoviva, Inc. (NASDAQ:…
Pilatus, Roche Partner on First-in-Human PLT012 Liver Cancer Trial
Pilatus Biosciences Launches Clinical Trial Collaboration with Roche to Advance First-in-Human Evaluation of PLT012 in Liver Cancer Pilatus Biosciences, Inc., a biotechnology company focused on developing innovative metabolic checkpoint immunotherapies…
Infinity Bio, AIT Partner to Offer Antibody Reactome Profiling in Europe
Infinity Bio Partners with Austrian Institute of Technology to Deliver Antibody Reactome Profiling Across Europe Infinity Bio, Inc., a pioneering leader in advanced immune system analysis, has announced a strategic…